Skip to main content
Sugentech, Inc. logo

Sugentech, Inc. — Investor Relations & Filings

Ticker · 253840 ISIN · KR7253840003 KO Manufacturing
Open in API
Filings indexed 297 across all filing types
Latest filing 2019-04-01 Annual Report
Country KR South Korea
Listing KO 253840

About Sugentech, Inc.

https://www.sugentech.com/en/

Sugentech, Inc. is an in-vitro diagnostics (IVD) company that develops and commercializes diagnostic solutions by integrating biotechnology, nanotechnology, and information technology. The company's product portfolio serves diverse healthcare settings, from large hospitals and laboratories to smaller clinics and home users. Key offerings include automated multi-immunoblot systems, point-of-care testing (POCT) platforms, and self-diagnostic kits for personal use, such as ovulation and pregnancy tests. Sugentech leverages proprietary technologies in developing high-level antibodies and advanced nanoparticles to create highly sensitive and precise immunochemical assays, underpinning its digital healthcare diagnostic platform for personalized medicine.

Recent filings

Filing Released Lang Actions
사업보고서 (2018.12)
Annual Report Classification · 100% confidence The document is a comprehensive 'Business Report' (사업보고서) for the fiscal year 2018, covering company overview, history, capital changes, and detailed business operations. It is a formal, long-form regulatory filing submitted to the Financial Services Commission and Korea Exchange. It contains substantive financial and operational data, fitting the definition of an Annual Report (10-K). FY 2018
2019-04-01 Korean
특허권취득(자율공시)
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent (특허권 취득) by Sugentech. It details the patent name, content, and utilization plan. Since this is a regulatory announcement of a corporate event that does not fall into specific categories like financial reports, M&A, or share transactions, it is classified as a general regulatory filing.
2019-03-29 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 95% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the granting of stock options (주식매수선택권 부여에 관한 신고). It details the number of shares, exercise price, and recipients of the stock options. This type of disclosure is a standard regulatory requirement for listed companies in Korea to report changes in capital structure or equity-based compensation, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like 'Director's Dealing' (which is for personal trades) or 'Share Issue' (which is for general capital changes).
2019-03-26 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회 결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, director/auditor remuneration limits, and stock option grants. Since it reports the official outcomes of shareholder votes at an AGM, it falls under the Declaration of Voting Results category.
2019-03-26 Korean
감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a short regulatory filing titled '감사보고서 제출' (Submission of Audit Report) by Sugentech. It provides a summary table of audit opinions and key financial figures (assets, liabilities, revenue, etc.) as reported by the external auditor (Samil PwC). Since the document is a brief announcement of the audit report submission rather than the full, comprehensive audit report document itself, it falls under the category of a report publication announcement. FY 2018
2019-03-19 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document specifically details changes in share ownership (a decrease in stake due to off-market sales) by a major shareholder (Daesung Private Equity). This falls under the category of Major Shareholding Notification (MRQ), as it reports changes in significant share ownership levels crossing regulatory thresholds.
2019-03-15 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.